申请人:Shanghai Hengrui Pharmaceutical Co., Ltd.
公开号:US20140329745A1
公开(公告)日:2014-11-06
The present invention provides a human insulin analogue, an acylated derivative thereof and a physiologically acceptable salt. The present invention further provides a preparation method for the insulin analogue and an application of the insulin analogue as a therapeutic agent, and particularly as a diabetes mellitus therapeutic agent.
本发明提供了一种人胰岛素类似物、其酰化衍生物和生理上可接受的盐。本发明还提供了一种制备胰岛素类似物的方法以及胰岛素类似物作为治疗剂的应用,特别是作为糖尿病治疗剂的应用。